RxDoctor Payments Data

Amelia Yeh

Pulmonary Disease · Abilene, TXNPI 1023183928

Payments from drug & device makers

$94,952in general payments, 2019–2025

Across 250 payments — averaging $379.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$92K
  • AstraZeneca$1K
  • Boehringer Ingelheim$932
  • Genentech USA, Inc.$184
  • United Therapeutics Corporation$183
  • Harmony Biosciences LLC$136
  • plus $584 from 12 others

What the payments were for

  • Consulting fees$4,8755%
  • Speaking & faculty fees$82,60087%
  • Travel & lodging$2,8073%
  • Food & beverage$4,4965%
  • Education$1740%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,952 in reported general payments places this provider in the 85th percentile of 904 pulmonary disease providers in Texas.

See all pulmonary disease providers in Texas

Other pulmonary disease in Abilene

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →